These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 31880267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX, Yi H, Qu JQ, He QY, Xiao ZQ.
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [Abstract] [Full Text] [Related]

  • 4. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
    Lung RW, Hau PM, Yu KH, Yip KY, Tong JH, Chak WP, Chan AW, Lam KH, Lo AK, Tin EK, Chau SL, Pang JC, Kwan JS, Busson P, Young LS, Yap LF, Tsao SW, To KF, Lo KW.
    J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G, Zong J, Lin S, Verhoeven RJ, Tong S, Chen Y, Ji M, Cheng W, Tsao SW, Lung M, Pan J, Chen H.
    Int J Cancer; 2015 Mar 01; 136(5):E301-12. PubMed ID: 25213622
    [Abstract] [Full Text] [Related]

  • 7. Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research.
    Zhang PF, Zheng XH, Li XZ, Tian T, Zhang SD, Hu YZ, Jia WH.
    Cancer Commun (Lond); 2018 Apr 12; 38(1):8. PubMed ID: 29764493
    [Abstract] [Full Text] [Related]

  • 8. LncRNA BC200 promotes the development of EBV-associated nasopharyngeal carcinoma by competitively binding to miR-6834-5p to upregulate TYMS expression.
    Zhang S, Liu N, Cao P, Qin Q, Li J, Yang L, Xin Y, Jiang M, Zhang S, Yang J, Lu J.
    Int J Biol Macromol; 2024 Oct 12; 278(Pt 4):134837. PubMed ID: 39179085
    [Abstract] [Full Text] [Related]

  • 9. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Ramayanti O, Verkuijlen SAWM, Novianti P, Scheepbouwer C, Misovic B, Koppers-Lalic D, van Weering J, Beckers L, Adham M, Martorelli D, Middeldorp JM, Pegtel DM.
    Int J Cancer; 2019 May 15; 144(10):2555-2566. PubMed ID: 30411781
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ, Zhou R, Zong JF, Lin WS, Tong S, Guo QJ, Lin C, Lin SJ, Chen YX, Chen MR, Chen HL, Ye YB, Pan JJ.
    Cancer Lett; 2019 Apr 10; 447():33-40. PubMed ID: 30684592
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma.
    Gao W, Li ZH, Chen S, Chan JY, Yin M, Zhang MJ, Wong TS.
    Oncotarget; 2017 Mar 21; 8(12):20297-20308. PubMed ID: 28423621
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.
    Wang D, Zeng Z, Zhang S, Xiong F, He B, Wu Y, Li W, Tang L, Wei F, Xiang B, Li Z, Zhou Y, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C.
    FASEB J; 2020 Jun 21; 34(6):8012-8027. PubMed ID: 32306460
    [Abstract] [Full Text] [Related]

  • 13. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
    Zheng XH, Wang RZ, Li XZ, Zhou T, Zhang JB, Zhang PF, Lu LX, Jia WH.
    Cancer Sci; 2020 Feb 21; 111(2):592-600. PubMed ID: 31834989
    [Abstract] [Full Text] [Related]

  • 14. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma.
    Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ, Chen HC.
    PLoS Pathog; 2014 Feb 21; 10(2):e1003974. PubMed ID: 24586173
    [Abstract] [Full Text] [Related]

  • 15. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Gao W, Wong TS, Lv KX, Zhang MJ, Tsang RK, Chan JY.
    Head Neck; 2019 Mar 21; 41(3):780-792. PubMed ID: 30548946
    [Abstract] [Full Text] [Related]

  • 16. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R, Tang LL, Mao YP, Du XJ, Chen L, Zhang ZC, Liu LZ, Tian L, Luo XT, Xie YB, Ren J, Sun Y, Ma J.
    Cancer; 2019 Jan 01; 125(1):79-89. PubMed ID: 30351466
    [Abstract] [Full Text] [Related]

  • 17. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review.
    Lee KT, Tan JK, Lam AK, Gan SY.
    Crit Rev Oncol Hematol; 2016 Jul 01; 103():1-9. PubMed ID: 27179594
    [Abstract] [Full Text] [Related]

  • 18. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH, Trung NQ, Dong LT, Trung LQ, Espinoza JL.
    J Cancer Res Clin Oncol; 2021 Mar 01; 147(3):713-723. PubMed ID: 33392659
    [Abstract] [Full Text] [Related]

  • 19. Effects of Dicer1 targeted by EBV-miR-BART6-5p on biological properties and radiosensitivity of nasopharyngeal carcinoma.
    Tang J, Liu ZY, Tang Y, Wang Y.
    Hum Exp Toxicol; 2021 Jun 01; 40(6):977-993. PubMed ID: 33305599
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
    Wu Y, Zhang X, Liu C, Li Z, Wen Y, Zheng R, Xu C, Tian J, Wei L, Wang J, Yan Q, Zheng X, Ma J.
    J Biol Chem; 2023 Sep 01; 299(9):105082. PubMed ID: 37495108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.